Last reviewed · How we verify
Tetrandrine
At a glance
| Generic name | Tetrandrine |
|---|---|
| Also known as | tetrandrine tablets |
| Sponsor | Peking University People's Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease (PHASE4)
- Tetrandrine Tablets Used in Hospitalized Adults With COVID-19 (PHASE4)
- Tetrandrine in the Treatment of Rheumatoid Arthritis (NA)
- Tetrandrine Tablets Used in the Treatment of COVID-19 (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |